First reported 19 hours ago -
Updated 19 hours ago -
1 reports
(NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA (miRNA) replacement therapies for cancer, announced that it has initiated a Phase 1 clinical study of MRX34, ...
[Published NewsRX - 19 hours ago]